ghk-cu peptide dosing protocol subcutaneous Dosage Chart: 50 mg Vial ghk-cu dosing subcutaneous Rejuvenation and

Last reviewed: May 31, 2026 Last updated: May 31, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

Active patients on GLP-1 therapy who are increasing exercise intensity and want musculoskeletal recovery support

Ghrelin and the synthetic secretagogues that mimic it does something subtler: it both adds a second push and briefly lifts the somatostatin brake, so the same GHRH signal produces a taller pulse

However, their clinical application requires rigorous evaluation of therapeutic efficacy, comprehensive safety profiling, and well-defined patient selection criteria